Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FR0ET
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,609
Award facts
- Contract value 100% obligated
- $17,609.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $17,609.06 to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 mg/ml syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The TREMFYA supply supports the Defense Health Agency's pharmaceutical procurement needs for military and veteran healthcare systems. TREMFYA (guselkumab) is a biologic immunosuppressant used primarily in the treatment of psoriasis and psoriatic arthritis. AmerisourceBergen's comprehensive IDC vehicle serves as a global pharmaceutical support mechanism, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The DLA continues to leverage this prime vendor arrangement as part of its broader medical supply chain operations supporting federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FR0ET?
SPE2DR26FR0ET was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FR0ET worth?
The government has obligated $17,609 on SPE2DR26FR0ET.
Is contract SPE2DR26FR0ET an order under another contract?
Yes. SPE2DR26FR0ET is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0ET competed?
The extent of competition for SPE2DR26FR0ET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award